Sepsis Clinical Trial
Official title:
The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)
NCT number | NCT01973829 |
Other study ID # | 12-007998 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 2013 |
Est. completion date | March 2018 |
Verified date | August 2018 |
Source | Mayo Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of the study is to test whether the health care provider access and training in CERTAIN (Checklist for Early Recognition and Treatment of Acute Illness), would facilitate timely and error free best-practice delivery and minimize preventable death and costly complications in critically ill patients.
Status | Completed |
Enrollment | 5215 |
Est. completion date | March 2018 |
Est. primary completion date | December 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion: All adult (= 18 years) patients admitted for the first time to the participating ICUs will be included. Exclusion: Not critically Ill, admitted for low risk monitoring, planned ICU admissions for routine postoperative surveillance for less than 24 hours after uncomplicated surgery, readmission and transferred from outside ICU. |
Country | Name | City | State |
---|---|---|---|
Belarus | Gomel Regional Clinical Hospital | Gomel | |
Bosnia and Herzegovina | University Hospital Banja Luka | Banja Luka | |
Bosnia and Herzegovina | Sveucilišna klinicka bolnica | Mostar | |
Bosnia and Herzegovina | Prim.Dr. Abdulah Nakaš | Sarajevo | |
Brazil | Hospital Israelita Albert Einstein | Sao Paulo | |
China | Beijing Hospital | Beijing | |
China | Guang An Men Hospital | Beijing | |
China | China West China Hospital | Chengdu | |
China | 1st Affiliated Hospital of Guangzhou Medical University | Guangzhusi | |
China | Anhui Province Hospital | Hefei | |
China | China Shanghai Changhai Hospital | Shanghai | |
China | Tianjin First Center Hospital | Tianjin | |
Croatia | KBC Rijeka | Rijeka | |
Dominican Republic | Centro De Diagnostica Imagenes Medicina Avanzada y Telemedicina CEDIMAT | Santo Domingo | |
India | Kasturba Hospital | Manial | Karnataka |
India | Lok Nayak Hospital | New Delhi | Delhi |
India | Ispat General Hospital | Raurkela | Odisha |
Ireland | St James Hosptial | Dublin | |
Mexico | Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ) | Mexico City | |
Mongolia | Central State University Hospital | Ulaanbaatar | |
Pakistan | Shaukat Khanum Memorial Cancer Hospital and Research Center | Lahore | |
Philippines | St. Luke's Medical Center | Manila | |
Philippines | The Med City Hospital | Manila | |
Poland | Heliodor Swiecicki Clinical Hospital at the Karol Marcinkowski Medical University in Poznan | Poznan | |
Saudi Arabia | King Abdulaziz Medical City, | Riyadh | |
Serbia | Military Medical Academy | Belgrade | |
Serbia | The Institute for pulmonary diseases of Vojvodina | Sremska Kamenica | |
Turkey | Akdeniz University Hospital | Antalya | |
Turkey | Gulhane Military Medical Faculty | Antalya | |
Uganda | International hospital Kampala | Kampala |
Lead Sponsor | Collaborator |
---|---|
Mayo Clinic |
Belarus, Bosnia and Herzegovina, Brazil, China, Croatia, Dominican Republic, India, Ireland, Mexico, Mongolia, Pakistan, Philippines, Poland, Saudi Arabia, Serbia, Turkey, Uganda,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Adherence to best critical care practices | Adherence to best practice in initial evaluation and treatment of critically ill medical and surgical patients Appropriate shock resuscitation Appropriate sepsis treatment Appropriate mechanical ventilation Appropriate peptic ulcer, deep vein thrombosis and infectious disease prophylaxis | Participants will be followed for the duration of ICU stay, an expected average of 2 weeks | |
Primary | ICU and hospital lengths of stay | Patient will be followed till they get discharged from hospital for whatever length they stay. | Participants will be followed for the duration of hospital stay, an expected average of 8 weeks | |
Secondary | Mortality for 4 weeks | Patient will be followed for 4 weeks and hospital discharge(up to total 10 weeks post discharge) | Participants will be followed for the duration of 4 weeks and hospital discharge (up to 10 weeks post discharge) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 |